Your browser doesn't support javascript.
loading
Top 10 Challenges in Cancer Immunotherapy.
Hegde, Priti S; Chen, Daniel S.
Affiliation
  • Hegde PS; Genentech Inc., South San Francisco, CA, USA.
  • Chen DS; IGM Biosciences, Mountain View, CA, USA. Electronic address: dschen@igmbio.com.
Immunity ; 52(1): 17-35, 2020 01 14.
Article in En | MEDLINE | ID: mdl-31940268
ABSTRACT
Cancer immunotherapy is a validated and critically important approach for treating patients with cancer. Given the vast research and clinical investigation efforts dedicated to advancing both endogenous and synthetic immunotherapy approaches, there is a need to focus on crucial questions and define roadblocks to the basic understanding and clinical progress. Here, we define ten key challenges facing cancer immunotherapy, which range from lack of confidence in translating pre-clinical findings to identifying optimal combinations of immune-based therapies for any given patient. Addressing these challenges will require the combined efforts of basic researchers and clinicians, and the focusing of resources to accelerate understanding of the complex interactions between cancer and the immune system and the development of improved treatment options for patients with cancer.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunotherapy / Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: Immunity Journal subject: ALERGIA E IMUNOLOGIA Year: 2020 Document type: Article Affiliation country: Estados Unidos

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunotherapy / Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: Immunity Journal subject: ALERGIA E IMUNOLOGIA Year: 2020 Document type: Article Affiliation country: Estados Unidos